LinKinVax has the trust of world-class partners and investors.

press releases

October 13, 2022

Accelerating the production of more effective prophylactic or therapeutic vaccines and adapting them to emerging or rapidly mutating pathogens is a major public health challenge.

May 20, 2022

LinKinVax puts together a highly experienced team from the world of biopharmaceuticals to lead the clinical development and upscaling of its vaccine platform

May 4, 2022

LinKinVax appoints Dr Jiong Ma as independent board member